how to ask your doctor for semaglutide In our latest the Spin Doctor, obesity medicine specialist Dr. Ian Rigby breaks down (Ozempic/Wegovy) people living with spinal cord injury. Key takeaways: Navigating Insurance Coverage for GLP-1

The ACHIEVE-3 study enrolled 1,698 adults with type 2 diabetes inadequately controlled on metformin and compared two doses of Foundayo with approved doses of oral semaglutide over 52 weeks. At the highest dose comparison, Foundayo 17.2 mg reduced A1C by an average of 2.2% from a baseline of 8.3%, compared with a 1.4% reduction for oral semaglutide 14 mg. The difference represented a 57.1% greater relative reduction in A1C. "ACHIEVE-3 provides the first head-to-head data on oral GLP-1s in type 2 diabetes, with orforglipron showing greater A1C and weight reductions than oral semaglutide." Julio Rosenstock, MD The treatment also produced greater weight loss

Start with the scaffold

Pretty much nothing worked

As the body of literature on this topic expands, more refined clinical guidance for the use of GLP-1RAs is expected to emerge

Who was studied

40 However, as outlined, latitude explains the greatest proportion of variability in UV exposure over other such measures, 30 with the correlation between latitude and UVR levels well represented by satellite data (Fig